NCT05039281 2025-12-19
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT03174197 2025-09-24
Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03673787 2025-05-14
IceCAP
Institute of Cancer Research, United Kingdom
Phase 1/2 Active not recruiting
NCT03158389 2023-09-28
N²M²
University Hospital Heidelberg
Phase 1/2 Completed